BRAND: Omeprazole Rowa
ACTIVE INGREDIENT: Omeprazole
STRENGTH, PACK SIZE & GMS CODES:
20 mg Gastro-Resistant Capsules, hard ~ 61853
40 mg Gastro-Resistant Capsules, hard ~ 36509
Omeprazole Rowa is indicated in:
Treatment of: duodenal ulcers, gastric ulcers, NSAID-associated gastric and duodenal ulcers, reflux esophagitis, symptomatic gastro-esophageal reflux disease, Zollinger-Ellison syndrome.
Prevention of: relapse of duodenal ulcers, relapse of gastric ulcers, NSAID-associated gastric and duodenal ulcers in patients at risk.
In combination with: appropriate antibiotics, Helicobacter pylori (H. pylori) eradication in peptic ulcer disease.
Long-term: management of patients with healed reflux esophagitis.
Children over 1 year of age and ≥ 10 kg
- Treatment of reflux esophagitis
- Symptomatic treatment of heartburn and acid regurgitation in gastro-esophageal reflux disease
Children and adolescents over 4 years of age
- In combination with antibiotics in treatment of duodenal ulcer caused by H. pylori